May 05, 2022 / 08:30PM GMT
Operator
Good day, ladies and gentlemen, and welcome to the Dynavax Technologies First Quarter 2022 Financial Results. As a reminder, this conference call is being recorded. (Operator Instructions)
I would now like to turn the call over to Nicole Arndt, Senior Manager, Investor Relations. You may begin.
Nicole Arndt - Dynavax Technologies Corporation - Senior Manager of IR
Thank you. Good afternoon, and welcome to the Dynavax First Quarter 2022 Financial Results and Corporate Update Conference Call. In addition to our press release issued today, a supplementary slide presentation that accompanies today's call is available in the Events section of our website.
Before we begin, I advise you that we will be making forward-looking statements today based on our current expectations and beliefs, including, but not limited to potential market size and market share, impact of ACIP recommendation, financial guidance and trends, expected regulatory filings or approvals of our collaborators, clinical readouts and potential future uses of CpG 1018 adjuvant. These
Q1 2022 Dynavax Technologies Corp Earnings Call Transcript
May 06, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers